Highlights of 2022

Jan

Breakthrough in protein expression

The strain engineering and manufacturing teams of Biotalys achieve a breakthrough in production capabilities for the active protein of EvocaTM in the yeast Pichia pastoris. This breakthrough has the potential to transform Evoca from a market calibration tool into a commercial product of competitive e icacy and cost to growers by 2026.

Partnership with Olon

Biotalys enters into a long-term strategic partnership with Olon for the manufacturing of Biotalys’ protein-based biocontrols. Relying on its leading expertise in microbial fermentation, Olon will manufacture Biotalys’ biocontrols beginning with Evoca.

Partnership with Kwizda Agro research to further develop the novel AGROBODY Foundry™ technology platform, preparing Biotalys’ pipeline for expansion and commercial availability.

Biotalys signs an agreement with Kwizda Agro, an established crop protection manufacturer and provider of tolling services for the agricultural industry, to act as the formulator of its biocontrol products. Kwizda Agro will formulate the liquid active ingredient into water-soluble granules that form the customer’s end product.

Mar

Appointment of Carlo Boutton as Chief Scientific Officer

The Company appoints Dr. Carlo Bou on as its new CSO. Dr. Bou on brings more than 20 years of antibody and biochemistry leadership to his new executive role at Biotalys. He will lead the team’s continued scientific

Apr

New Board member Michiel van Lookeren

Campagne

Biotalys appoints Dr. Michiel van Lookeren Campagne to its Board of Directors. With decades of experience driving scientific advances for the agricultural industry, he brings valuable perspectives to the Board in support of the Company’s e orts to make protein-based biocontrols a standard part of the crop and food protection toolkit in the years ahead.

May

New key finding in grapes

Field trials with Evoca in the US showed that, when applied at the flowering stage in a Botrytis control program in grapes, the product consistently outperformed a leading chemical fungicide. This demonstrates Evoca’s potential as a pivotal tool to fight Botrytis.

New FRAC code for EvocaTM

The Fungicide Resistance Action Committee (FRAC) grants an entirely new class for the active ingredient of our first biofungicide, Evoca. This new classification, granted by a highly-reputed international panel of renowned technical experts, demonstrates to growers that Evoca will be a new tool that complements existing biological and conventional crop protection solutions to fight the fungal diseases Botrytis and powdery mildew.

World BioProtection Award for EvocaTM

Evoca wins the World BioProtection Award 2022 for Best Biofungicide Product. The award was granted at the World BioProtection Summit taking place in Birmingham (UK), based on the innovative character, scientific value and market potential of the product

Jun

Partnership with Novozymes

The partnership with Biotalys provides that Novozymes will use its expertise, intellectual property rights and know-how to explore additional routes for the upscaling and production of the bioactive protein of Evoca, with the option of a possible commercial collaboration for a future generation of the product.

Sep

Employee visit to EvocaTM greenhouse trials

Our employees visit the greenhouses of our partner Botany in The Netherlands. It o ers them a great opportunity to see the performance of Evoca on tomatoes, strawberries and cucumbers and to discuss and exchange thoughts with growers and distributors of fruit and vegetable production.